|
1
|
Tse DT, Benedetto P, Dubovy S, Schiffman
JC and Feuer WJ: Clinical analysis of the effect of intraarterial
cytoreductive chemotherapy in the treatment of lacrimal gland
adenoid cystic carcinoma. Am J Ophthalmol. 141:44–53.
2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bernardini FP, Devoto MH and Croxatto JO:
Epithelial tumors of the lacrimal gland: An update. Curr Opin
Ophthalmol. 19:409–413. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
von Holstein SL, Fehr A, Persson M,
Therkildsen MH, Prause JU, Heegaard S and Stenman G: Adenoid cystic
carcinoma of the lacrimal gland: MYB gene activation, genomic
imbalances, and clinical characteristics. Ophthalmology.
120:2130–2138. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sanders JC, Mendenhall WM and Werning JW:
Adenoid cystic carcinoma of the lacrimal gland. Am J Otolaryngol.
37:144–147. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Han J, Kim YD, Woo KI and Sobti D:
Long-term outcomes of eye-sparing surgery for adenoid cystic
carcinoma of lacrimal gland. Ophthalmic Plast Reconstr Surg.
34:74–78. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Woo KI, Yeom A and Esmaeli B: Management
of lacrimal gland carcinoma: Lessons from the literature in the
past 40 years. Ophthalmic Plast Reconstr Surg. 32:1–10.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chae YK, Chung SY, Davis AA, Carneiro BA,
Chandra S, Kaplan J, Kalyan A and Giles FJ: Adenoid cystic
carcinoma: Current therapy and potential therapeutic advances based
on genomic profiling. Oncotarget. 6:37117–37134. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mallen-St Clair J, Arshi A, Tajudeen B,
Abemayor E and St John M: Epidemiology and treatment of lacrimal
gland tumors: A population-based cohort analysis. JAMA Otolaryngol
Head Neck Surg. 140:1110–1116. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lesueur P, Rapeaud E, Marzi LD, Goudjil F,
Levy C, Galatoire O, Jacomet PV, Dendale R and Calugaru V: Adenoid
cystic carcinoma of the lacrimal gland: High dose adjuvant proton
therapy to improve patients outcomes. Front Oncol.
10(135)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Polanowski PA, Księżniak-Baran DA,
Grządziel AB, Pietruszka A, Chmielik E, Pilecki B, Amrogowicz N,
Gajda K and Składowski K: Successful treatment of adenoid cystic
carcinoma with the application of a high-dose stereotactic body
radiotherapy boost. Case Rep Oncol. 14:371–377. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang CC and Goodman M: Photon irradiation
of unresectable carcinomas of salivary glands. Int J Radiat Oncol
Biol Phys. 21:569–576. 1991.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mendenhall WM, Morris CG, Amdur RJ,
Werning JW, Hinerman RW and Villaret DB: Radiotherapy alone or
combined with surgery for adenoid cystic carcinoma of the head and
neck. Head Neck. 26:154–162. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Esmaeli B, Golio D, Kies M and DeMonte F:
Surgical management of locally advanced adenoid cystic carcinoma of
the lacrimal gland. Ophthalmic Plast Reconstr Surg. 22:366–370.
2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
De Haan LD, De Mulder PH, Vermorken JB,
Schornagel JH, Vermey A and Verweij J: Cisplatin-based chemotherapy
in advanced adenoid cystic carcinoma of the head and neck. Head
Neck. 14:273–277. 1992.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Papaspyrou G, Hoch S, Rinaldo A, Rodrigo
JP, Takes RP, van Herpen C, Werner JA and Ferlito A: Chemotherapy
and targeted therapy in adenoid cystic carcinoma of the head and
neck: A review. Head Neck. 33:905–911. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Licitra L, Cavina R, Grandi C, Palma SD,
Guzzo M, Demicheli R and Molinari R: Cisplatin, doxorubicin and
cyclophosphamide in advanced salivary gland carcinoma. A phase II
trial of 22 patients. Ann Oncol. 7:640–642. 1996.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Laurie SA, Ho AL, Fury MG, Sherman E and
Pfister DG: Systemic therapy in the management of metastatic or
locally recurrent adenoid cystic carcinoma of the salivary glands:
A systematic review. Lancet Oncol. 12:815–824. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li J, Ludmire EB, Wang Y, et al:
Stereotactic radiosurgery versus whole-brain radiation therapy for
patients with 4-15 brain metastases: A phase III randomized
controlled trial. Lecture presented at the American Society for
Radiation Oncology (ASTRO) Annual Meeting, October 24-28, 2020.
|
|
19
|
Andrews DW, Scott CB, Sperduto PW,
Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J,
Bahary JP, et al: Whole brain radiation therapy with or without
stereotactic radiosurgery boost for patients with one to three
brain metastases: Phase III results of the RTOG 9508 randomised
trial. Lancet. 363:1665–1672. 2004.PubMed/NCBI View Article : Google Scholar
|
